Executive Director of Research & Development
Igor Nikoulin, Ph.D.
Dr. Nikoulin established and directs the R&D and manufacturing capabilities for all dosage forms including nanoparticle-based drug delivery systems at IRISYS since joining the Company in 2013. He has extensive knowledge and experience in small molecule, peptide, and protein formulation development, and lipid- / polymer-based micro- and nanoparticle targeted drug delivery systems.
Dr. Nikoulin has 14 years of academic and 16 years of drug discovery and development experience serving as a project leader and team leader/principal investigator, as well as experience working in GMP and GLP compliant labs. Prior to IRISYS, Dr. Nikoulin directed research and development projects in the areas of cardiovascular, inflammatory, and metabolic diseases at Avanir Pharmaceuticals. He initiated and advanced a research and development project from concept to the filing of an IND. His varied responsibilities ranged from setting up and supervising the laboratories to coordinating the efforts of cross-functional teams, and academic and industry partners.
Dr. Nikoulin was awarded a Ph.D. in Biochemistry from the Moscow Institute of Medical Enzymology. He received a BS/MS from Moscow State University, Department of Biochemistry.